Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
(E,E)-Bisdemethoxycurcumin
Cat. No.:
OB0425LY-399
Appearance:
Solid
Purity:
≥98.0%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
(E,E)-Bisdemethoxycurcumin is a derivative of curcumin with anti-inflammatory, antioxidant, and anticancer activities,.
Synonyms:
Bisdemethoxycurcumin; 33171-05-0; (1E,6E)-1,7-Bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione; Bis(4-hydroxycinnamoyl)methane; Bis-demethoxycurcumin; Bisdemethoxycucurmin; (E,E)-Bisdemethoxycurcumin
CAS No.:
33171-05-0
Compound CID:
5315472
Formula:
C19H16O4
Formula Weight:
308.33
Specification
Target:
Apoptosis; Autophagy
Pathway:
Apoptosis; Autophagy
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
(E,E)-Bisdemethoxycurcumin can be used in areas such as drug development and functional foods.
